Septic shock after treatment of pyoderma gangrenosum with infliximab

Acta Derm Venereol. 2009;89(1):93-4. doi: 10.2340/00015555-0540.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Dermatologic Agents / adverse effects*
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Pyoderma Gangrenosum / drug therapy*
  • Shock, Septic / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Infliximab